Fidelity Investments’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$177K Sell
194,890
-9,216
-5% -$8.36K ﹤0.01% 3356
2025
Q1
$92.2K Buy
204,106
+3,201
+2% +$1.45K ﹤0.01% 3589
2024
Q4
$101K Buy
200,905
+194,495
+3,034% +$97.7K ﹤0.01% 3541
2024
Q3
$5.8K Buy
6,410
+4,537
+242% +$4.11K ﹤0.01% 4584
2024
Q2
$1.87K Sell
1,873
-228
-11% -$227 ﹤0.01% 4729
2024
Q1
$3.11K Buy
2,101
+751
+56% +$1.11K ﹤0.01% 4611
2023
Q4
$1.47K Sell
1,350
-94
-7% -$102 ﹤0.01% 4701
2023
Q3
$1.7K Sell
1,444
-649
-31% -$766 ﹤0.01% 4576
2023
Q2
$2.95K Buy
2,093
+1,249
+148% +$1.76K ﹤0.01% 4503
2023
Q1
$1.27K Buy
844
+62
+8% +$93 ﹤0.01% 4708
2022
Q4
$915 Sell
782
-236
-23% -$276 ﹤0.01% 4669
2022
Q3
$1K Sell
1,018
-4,408
-81% -$4.33K ﹤0.01% 4697
2022
Q2
$9K Buy
5,426
+3,744
+223% +$6.21K ﹤0.01% 4143
2022
Q1
$2K Buy
1,682
+1,680
+84,000% +$2K ﹤0.01% 4676
2021
Q4
$0 Hold
2
﹤0.01% 4696
2021
Q3
$0 Sell
2
-3
-60% ﹤0.01% 4734
2021
Q2
$0 Buy
+5
New ﹤0.01% 4604
2020
Q1
Sell
-500
Closed 3996
2019
Q4
$0 Buy
+500
New ﹤0.01% 4065
2019
Q3
Sell
-493
Closed -$1K 4044
2019
Q2
$1K Buy
493
+473
+2,365% +$959 ﹤0.01% 3614
2019
Q1
$0 Buy
+20
New ﹤0.01% 3950
2014
Q1
Sell
-759,946
Closed -$2.21M 2687
2013
Q4
$2.21M Sell
759,946
-1,038,480
-58% -$3.02M ﹤0.01% 2333
2013
Q3
$5.52M Sell
1,798,426
-82,270
-4% -$252K ﹤0.01% 2131
2013
Q2
$6.01M Buy
+1,880,696
New +$6.01M ﹤0.01% 2086